Safety of fluralaner, a novel systemic antiparasitic drug, in MDR1(-/-) Collies after oral administration-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety of fluralaner, a novel systemic antiparasitic drug, in MDR1(-/-) Collies after oral administration

Published:2014 Issue:1 Volume:7 Page:86
ISSN:1756-3305
Container-title:Parasites & Vectors
language:en
Short-container-title:Parasites & Vectors

Author:

Walther Feli M,Paul Allan J,Allan Mark J,Roepke Rainer KA,Nuernberger Martin C

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Parasitology

Reference12 articles.

1. The antiparasitic isoxazoline A1443 is a potent blocker of insect ligand-gated chloride channels

2. A randomized, blinded, controlled and multi-centered field study comparing the efficacy and safety of Bravecto™ (fluralaner) against Frontline™ (fipronil) in flea- and tick-infested dogs

3. The physiological function of drug-transporting P-glycoproteins

4. Breed distribution and history of canine mdr1-1 , a pharmacogenetic mutation that marks the emergence of breeds from the collie lineage

5. Frequency of the nt230 (del4) MDR1 mutation in Collies and related dog breeds in Germany

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic and pharmacodynamic considerations for treating sarcoptic mange with cross-relevance to Australian wildlife;International Journal for Parasitology: Drugs and Drug Resistance;2023-04

2. Canine and feline P‐glycoprotein deficiency: What we know and where we need to go;Journal of Veterinary Pharmacology and Therapeutics;2022-11-03

3. Canine mange part 2: treatment and management;Companion Animal;2022-11-02

4. Pathophysiological and Pharmaceutical Considerations for Enhancing the Control of Sarcoptes scabiei in Wombats Through Improved Transdermal Drug Delivery;Frontiers in Veterinary Science;2022-06-28

5. Safety of oral afoxolaner formulated with or without milbemycin oxime in homozygous MDR1 ‐deficient collie dogs;Journal of Veterinary Pharmacology and Therapeutics;2022-05-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3